We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$871M
AUM Growth
+$146M
Cap. Flow
+$118M
Cap. Flow %
13.5%
Top 10 Hldgs %
47.29%
Holding
141
New
32
Increased
44
Reduced
18
Closed
28

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$43.2M
2
BMY icon
Bristol-Myers Squibb
BMY
+$32M
3
VTRS icon
Viatris
VTRS
+$17.7M
4
ARGX icon
argenx
ARGX
+$12.1M
5
IMMU
Immunomedics Inc
IMMU
+$9.29M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$21.4M
2
AMGN icon
Amgen
AMGN
+$18.5M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$15.6M
4
BIIB icon
Biogen
BIIB
+$14.5M
5
PFE icon
Pfizer
PFE
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 75.17%
2 Technology 4.8%
3 Industrials 2.36%
4 Financials 1.58%
5 Materials 0.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMX
101
DELISTED
Terminix Global Holdings, Inc.
TMX
$395K 0.05%
14,184
– –
ABUS icon
102
Arbutus Biopharma
ABUS
$857M
$378K 0.04%
+40,000
New +$397K
EIDX
103
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$315K 0.04%
31,522
+20,694
+191% +$340K
BNTC icon
104
Benitec Biopharma
BNTC
$402M
$294K 0.03%
+471
New +$322K
LOW icon
105
Lowe's Companies
LOW
$117B
$287K 0.03%
+2,500
New +$260K
CLRB icon
106
Cellectar Biosciences
CLRB
$20.5M
$263K 0.03%
+292
New +$344K
ULTI
107
DELISTED
Ultimate Software Group Inc
ULTI
$258K 0.03%
800
– –
CISN
108
DELISTED
Cision Ltd. Ordinary Share
CISN
$252K 0.03%
15,000
– –
SITE icon
109
SiteOne Landscape Supply
SITE
$4.12B
$226K 0.03%
3,000
– –
CMCSA icon
110
Comcast
CMCSA
$85B
$212K 0.02%
+5,993
New +$212K
CUE icon
111
Cue Biopharma
CUE
$113M
$181K 0.02%
+667
New +$193K
AMGN icon
112
Amgen
AMGN
$208B
– –
-100,000
Closed -$18.5M
BIIB icon
113
Biogen
BIIB
$30B
– –
-50,000
Closed -$14.5M
DK icon
114
Delek US
DK
$4.16B
– –
-24,533
Closed -$1.23M
KRNT icon
115
Kornit Digital
KRNT
$705M
– –
-130,831
Closed -$2.33M
KURA icon
116
Kura Oncology
KURA
$800M
– –
-351,953
Closed -$6.41M
LRCX icon
117
Lam Research
LRCX
$367B
– –
-145,970
Closed -$2.52M
META icon
118
Meta Platforms (Facebook)
META
$1.42T
– –
-19,100
Closed -$3.71M
MHK icon
119
Mohawk Industries
MHK
$7.5B
– –
-1,100
Closed -$236K
MRVL icon
120
Marvell Technology
MRVL
$168B
– –
-109,842
Closed -$2.35M
NGNE icon
121
Neurogene
NGNE
$656M
– –
-12,881
Closed -$683K
NICE icon
122
Nice
NICE
$5.79B
– –
-60,043
Closed -$6.23M
OEF icon
123
PUT
iShares S&P 100 ETF
OEF
$20.1B
– –
-150,000
Closed -$24.6M
PFE icon
124
Pfizer
PFE
$143B
– –
-411,060
Closed -$14.1M
RCKT icon
125
Rocket Pharmaceuticals
RCKT
$340M
– –
-34,475
Closed -$677K
2 3 4
5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2018 Portfolio in Review

As of Q3 2018, Sphera Funds Management held 141 positions worth $871M, up 20% from $725M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sphera Funds Management deployed $118M of net new capital in Q3 2018, opening 32 new positions and adding to 44 existing holdings. Its largest new stake was Johnson & Johnson: 325,000 shares worth $44.9M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 72% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $15.6M trimmed.

  • Sphera Funds Management's largest Q3 2018 buy was Johnson & Johnson: 325,000 shares worth $44.9M.
  • Sphera Funds Management added most to Viatris in Q3 2018, an estimated $17.7M increase.
  • Sphera Funds Management's biggest Q3 2018 reduction was Alnylam Pharmaceuticals, cutting an estimated $15.6M.
  • Sphera Funds Management fully exited Shire pic in Q3 2018, selling an estimated $21.4M.
  • Sphera Funds Management's ten largest holdings make up 47% of its $871M portfolio in Q3 2018.
  • Sphera Funds Management opened 32 new positions and closed 28 in Q3 2018.
  • Sphera Funds Management's portfolio value rose 20% quarter-over-quarter to $871M.

Based on Sphera Funds Management's 13F filing for Q3 2018, filed 14 Nov 2018.